Search

Bottom line recommendations for cannabis intoxication. Published online: December 2021

Bottom Line Recommendations for treatment and management of cannabis intoxication. Published online March 2022. 

Formulations and methods of delivery table for cannabis. Uploaded 2021-12-06

Formulations andmethods of delivery table for cannabis. Uploaded online: March 2022

The purpose of this was to outline recommendations for clincians treating pediatric patients with actue cannabis intoxication.

To analyze published reports of unintentional cannabis ingestions in children to determine presenting signs and symptoms, route of exposure, treatment, and outcome.

To summarize the available evidence on CHS diagnosis, pathophysiology, and treatment.

Cannabis and its principal active constituent, 9-tetrahydrocannabinol (THC), are increasingly available as edibles resembling commercially available food products. In this case series, we describe a population of predominantly pediatric patients who were inadvertently exposed to a THC-containing product in San Francisco.

We sought to evaluate the French national trend of admissions for unintentional cannabis intoxication in children over an 11-year period (20042014).

Here, we report five cases of acute intoxication by synthetic cannabinoids 5F-ADB and MMB-2201 with analytical confirmation

In this report, we describe two adolescent patients admitted after they inhaled K2, resulting in loss of consciousness, tachycardia, and diffuse pain.

This is a case study of a young girl experiencing cannabis usage.

This study aimed to evaluate the process of identifying marijuana exposure in a children's hospital emergency department and compare the cost of diagnostic testing and procedures.

We describe the clinical effects of, and products associated with, acute exposures to cannabis during the early legalization period of recreational cannabis in Oregon and Alaska.

We report the case of a 13-month-old female presenting with self-limiting altered mental status and lethargy, with a subsequent diagnosis of tetrahydrocannabinol exposure on confirmatory urine gas chromatography-mass spectrometry.

We present a retrospective, descriptive study of patients aged 3 years or younger who were treated for cannabis poisoning in a pediatric emergency department between 2012 and 2017.

We carried out a retrospective cohort study of children admitted to a pediatric emergency department due to unintentional cannabis exposure over a 10-year period from 2004 to 2014.

This report examines the concentration of cannabinoids in illicit cannabis products seized by the U.S. Drug Enforcement Administration over the last 2 decades, with particular emphasis on (9)-tetrahydrocannabinol and cannabidiol.

A systematic study was conducted of smoke exposure on drug-free participants.

This report examines the concentration of cannabinoids in illicit cannabis products seized by the U.S. Drug Enforcement Administration over the last 2 decades, with particular emphasis on (9)-tetrahydrocannabinol and cannabidiol.

The study was designed to produce extreme cannabis smoke exposure conditions tolerable to drug-free nonsmokers

This article will describe the pharmacology of cannabis, effects of various dosage formulations, therapeutics benefits and risks of cannabis for pain and muscle spasm, and safety concerns of medical cannabis use.

The objective of this study was to characterize the clinical picture and management of synthetic cannabinoid exposure in a cohort of adolescents.

This study aimed to explore a dose-response relationship of delta-9-tetrahydrocannabinol (THC) in THC-nave children after unintentional acute exposure and compare clinical outcomes with non-nave children.

We investigated both directions of association within an adolescent birth cohort: the association of social cognition with subsequent substance use, and the association of early substance use with subsequent social cognition

Drug misuse is a disturbing, common practice among youth. One in 4 American adolescents reports consuming prescription medications without a clinical indication. We sought to explore current trends of drug misuse in adolescents.

We studied children ages 1 mo to 2 y hospitalized with bronchiolitis in Colorado from 2013 to 2015.

To compare the incidence of pediatric marijuana exposures evaluated at a children's hospital and regional poison center (RPC) in Colorado before and after recreational marijuana legalization and to compare population rate trends of RPC cases for marijuana exposures with the rest of the United States.

This study investigates marijuana exposures among children <6 years old in the United States using data from the National Poison Data System.

We present 2 cases of actual or highly suspected synthetic cannabinoid exposure in 2 pediatric patients to demonstrate the wide range of symptoms that can be present in these patients.

Presents a case study of a 3 year old with acute cannabis intoxication.

A study of incidental pediatric cannabis consumption over a 4-year period.

To our knowledge, this is the first reported case of dexmedetomidine use to support a cannabis intoxicated patient.

This technical report updates the 2004 American Academy of Pediatrics technical report on the legalization of marijuana

The review emphasizes the importance for clinicians to be alert to the possibility of this substance as a precipitating factor for acute asthma.

This article will describe the pharmacology of cannabis, effects of various dosage formulations, therapeutics benefits and risks of cannabis for pain and muscle spasm, and safety concerns of medical cannabis use.

This study aims to describe trends in substance use and screening in the Canadian pediatric trauma population.

A prospective study assessed whether routine urine drug screens might alter the management of overdose patients.

To determine if there is a significant prevalence of drug or alcohol use among adolescents evaluated for significant acute trauma.